stockrow
Friday 6 November 2026
Export RVPH’s income statement to Excel — free account
Reviva Pharmaceuticals Holdings, Inc.
RVPH Healthcare Biotechnology
- EPS
- +92.1%
- Free cash flow
- +57.8%
Quarter to June 2026, against a year earlier
0.37
0.03
+8.82%
Follow RVPH
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
3.56 | 3.85 | 2.08 | 1.39 |
+8 more quarters Free account |
Net Debt/EBITDA |
7.60 | 6.78 | 4.06 | 3.27 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.86 | 1.19 | 1.72 | 1.39 | |
Interest Coverage |
(902.59) | (488.36) | 635.54 | (1,549.92) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.16) | (0.54) | (1.60) | (1.54) | |
Cash per Share |
1.51 | 3.16 | 3.98 | 3.63 | |
Shareholders Equity per Share |
1.15 | 2.48 | 2.38 | 1.25 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.15 | 2.48 | 2.38 | 1.25 | |
Free Cash Flow |
(2.12) | (3.80) | (5.80) | (5.59) | |
Working Capital |
15.21 | 17.44 | 7.83 | 3.77 | |
Net Current Asset Value |
15.21 | 17.44 | 7.83 | 3.73 | |
| Other line items | |||||
Quick Ratio |
3.35 | 3.63 | 1.98 | 1.35 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.16) | (0.54) | (1.60) | (1.54) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
3.71 | 3.40 | 4.65 | 7.10 | |
Average Assets |
16.39 | 15.32 | 15.71 | 10.98 | |
Average Common Equity |
7.37 | 6.49 | 4.73 | (2.72) |
Columns are period end dates · fundamentals updated 2 Nov 2026